Filing Details

Accession Number:
0001214659-22-000947
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-20 16:57:28
Reporting Period:
2022-01-19
Accepted Time:
2022-01-20 16:57:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1576263 Mirati Therapeutics Inc. MRTX Pharmaceutical Preparations (2834) 462693615
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1781315 M Julie Cherrington C/O Mirati Therapeutics, Inc.
3545 Cray Court
San Diego CA 92121
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-01-19 1,475 $116.07 2,546 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2021.